New SEC Form D filing
Chronicle Bio, Inc., 2026-11-12
A new SEC Form D private-offering notice from Menlo Park, CA, a $1,000,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
AI driven biobank and data platform for complex chronic conditions such as POTS, ME/CFS, and Long COVID
Filed 7 days agoFiled to raise $1,000,000First money in 2026-10-28Raised so far $250,000HQ (as filed) Menlo Park, CASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified chroniclebio.com↗Named in the filing 4 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Duke & Daisy, Inc., 2026-11-12, $150K, Foster City, CA
- Nanopath Inc, 2026-11-13, $36.8M, Cambridge, MA
- Loti Holdings, Inc., 2026-11-12, $5.1M, Alameda, CA
- Ora Biomedical, Inc., 2026-11-13, $1M, Seattle, WA
- Aloha Hospitality Group LLC, 2026-11-12, $3M, Lawndale, CA
- Neuvivo, Inc., 2026-11-13, $9.5M, Palo Alto, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.